The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
The promise of cancer vaccines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Mutated self antigens result from somatic mutations in normal gene products, reflecting the genetic instability of tumour cell”
BackgroundIwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,534
Shimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,460
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
The immune system evolved to discriminate infectious nonself from noninfectious self
Janeway, C. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90198-g · Cited by 1,342
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Immunity to Methylcholanthrene-Induced Sarcomas
(1957) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/18.6.769 · Cited by 1,229
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,062
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020 · cited 1×
“For example, inhibiting Ctla4 function can elicit autoimmune manifestations in mic”
BackgroundSutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Chambers, C. A., Kuhns, M. S., Egen, J. G., & Allison, J. P. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.565 · Cited by 998
Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off
Parijs, L. V., & Abbas, A. K. (1998) · Science · doi:10.1126/science.280.5361.243 · Cited by 965
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
A very high level of crossreactivity is an essential feature of the T-cell receptor
Mason, D. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01299-7 · Cited by 945
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
Self-citationT-cell regulation by CD28 and CTLA-4
Alegre, M.-L., Frauwirth, K. A., & Thompson, C. B. (2001) · Nature Reviews Immunology · doi:10.1038/35105024 · Cited by 914
Carreno, B. M., & Collins, M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 896
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
CD27 is required for generation and long-term maintenance of T cell immunity
Hendriks, J., Gravestein, L. A., Tesselaar, K., van Lier, R. A. W., Schumacher, T. N. M., & Borst, J. (2000) · Nature Immunology · doi:10.1038/80877 · Cited by 779
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
A fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
Klein, G., Sjögren, H. O., Klein, E., & Hellström, K. E. (1960) · PubMed · Cited by 742
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
The role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672
A Mutator Phenotype in Cancer 1
Loeb, L. A. (2001) · Cited by 670
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Occurrence of malignancy in immunodeficiency diseases: A literature review
Gatti, R. A., & Good, R. A. (1971) · Cancer · doi:10.1002/1097-0142(197107)28:1<89::aid-cncr2820280117>3.0.co;2-q · Cited by 632
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., & Zanovello, P. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00132-7 · Cited by 592
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
Qin, Z., & Blankenstein, T. (2000) · Immunity · doi:10.1016/s1074-7613(00)80218-6 · Cited by 511
CD4 T Cells and Their Role in Antitumor Immune Responses
Toes, R. E. M., Ossendorp, F., Offringa, R., & Melief, C. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.753 · Cited by 508
Alexander-Miller, M. A., Leggatt, G. R., & Berzofsky, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4102 · Cited by 501
SELECTION OF THE T CELL REPERTOIRE
Sebzda, E., Mariathasan, S., Ohteki, T., Jones, R., Bachmann, M. F., & Ohashi, P. S. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.829 · Cited by 495
Hewitt, H. B., Blake, E. R., & Walder, A. S. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.37 · Cited by 474
No one is naive: the significance of heterologous T-cell immunity
Welsh, R. M., & Selin, L. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri820 · Cited by 463
Kusmartsev, S. A., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E. M., Lush, R. M., & Gabrilovich, D. I. (2003) · PubMed · Cited by 460
Fields, R. C., Shimizu, K., & Mulé, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9482 · Cited by 454
Steinman, R. M. (2002) · Medical Entomology and Zoology · Cited by 446
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., & Reisfeld, R. A. (2002) · Nature Medicine · doi:10.1038/nm1202-794 · Cited by 400
Impact of Negative Selection on the T Cell Repertoire Reactive to a Self-Peptide
Bouneaud, C., Kourilsky, P., & Bousso, P. (2000) · Immunity · doi:10.1016/s1074-7613(00)00080-7 · Cited by 391
CD4+T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D., & Schreiber, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8633 · Cited by 384
The Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Self-citationOverwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
Zeh, H. J., Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., & Yang, J. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.989 · Cited by 376
A cancer therapy resistant to resistance
Kerbel, R. S. (1997) · Nature · doi:10.1038/36978 · Cited by 369
Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A., Naoe, M., Lebkowski, J. S., Vieweg, J., & Gilboa, E. (2000) · Nature Medicine · doi:10.1038/79519 · Cited by 348
Self-citationDendritic Cells as Sensors of Infection
e Sousa, C. R. (2001) · Immunity · doi:10.1016/s1074-7613(01)00136-4 · Cited by 319
Emerging clinical applications of RNA
Sullenger, B. A., & Gilboa, E. (2002) · Nature · doi:10.1038/418252a · Cited by 318
Self-citationBoczkowski, D., Nair, S. K., Nam, J., Lyerly, H. K., & Gilboa, E. (2000) · PubMed · Cited by 313
Self-citationSpeiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
T cell homeostatic proliferation elicits effective antitumor autoimmunity
Dummer, W., Niethammer, A. G., Baccalà, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., & Theofilopoulos, A. N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15175 · Cited by 308
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Adler, A. J., Marsh, D. W., Yochum, G. S., Guzzo, J. L., Nigam, A., Nelson, W. G., & Pardoll, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1555 · Cited by 294
Greenberg, P. D., Kern, D. E., & Cheever, M. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1122 · Cited by 292
Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Parmiani, G., Storkus, W. J., & Lotze, M. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118958 · Cited by 289
Biragyn, A., Surenhu, M., Yang, D., Ruffini, P. A., Haines, B. A., Klyushnenkova, E., Oppenheim, J. J., & Kwak, L. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6644 · Cited by 286
Homeostatic T Cell Proliferation
Surh, C. D., & Sprent, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.f9 · Cited by 277
T cell homeostatic proliferation elicits effective antitumor autoimmunity
Dummer, W., Niethammer, A. G., Baccala, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., & Theofilopoulos, A. N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215175 · Cited by 270
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Wang, R.-F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01896-8 · Cited by 266
Andersen, M. H., Pedersen, L. Ø., Capeller, B., Bröcker, E. B., Becker, J. C., & Straten, P. T. (2001) · PubMed · Cited by 255
Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., & Zinkernagel, R. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.795 · Cited by 252
Interleukin 7 induces CD4+ T cell-dependent tumor rejection.
Hock, H., Dorsch, M., Diamantstein, T., & Blankenstein, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1291 · Cited by 247
Morgan, D. J., Kreuwel, H. T. C., Fleck, S., Levitsky, H. I., Pardoll, D. M., & Sherman, L. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.643 · Cited by 244
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanović, S., Ockert, D., Rammensee, H., & Rieber, E. P. (2000) · PubMed · Cited by 243
Kerbel, R. S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B. L., & Rak, J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013172910858 · Cited by 237
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
Wei, Y.-Q., Wang, Q.-R., Zhao, X., Yang, L., Tian, L., Lu, Y., Kang, B., Lu, C.-J., Huang, M.-J., Lou, Y.-Y., et al. (2000) · Nature Medicine · doi:10.1038/80506 · Cited by 233
Tumors of the Immunocompromised Patient
Penn, I. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.000431 · Cited by 229
Read, S., & Powrie, F. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00273-4 · Cited by 228
Heterologous immunity: an overlooked barrier to tolerance
Adams, A. B., Pearson, T. C., & Larsen, C. P. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00082.x · Cited by 215
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Santulli-Marotto, S., Nair, S. K., Rusconi, C. P., Sullenger, B. A., & Gilboa, E. (2003) · PubMed · Cited by 214
Self-citationDvorak, H. F., Nagy, J. A., & Dvořàk, A. M. (1991) · PubMed · Cited by 203
Kersh, G. J., & Allen, P. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1259 · Cited by 199
Van den Eynde, B. J., & Morel, S. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00197-7 · Cited by 196
New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
(2000) · Advances in Cancer Research · doi:10.1016/s0065-230x(00)79001-4 · Cited by 193
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
Levitsky, H. I., Lazenby, A., Hayashi, R. J., & Pardoll, D. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1215 · Cited by 189
Heiser, A., Dahm, P., R. Yancey, D., Maurice, M. A., Boczkowski, D., Nair, S. K., Gilboa, E., & Vieweg, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5508 · Cited by 187
Self-citationAsavaroengchai, W., Kotera, Y., & Mulé, J. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022634999 · Cited by 169
Borrello, I., Sotomayor, E. M., Rattis, F.-M., Cooke, S. K., Gu, L., & Levitsky, H. I. (2000) · Blood · doi:10.1182/blood.v95.10.3011 · Cited by 167
Paraneoplastic neurological degenerations: keys to tumour immunity
Albert, M. L., & Darnell, R. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1255 · Cited by 166
Dittel, B. N., Visintin, I., Merchant, R. M., & Janeway, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.32 · Cited by 165
Nair, S., McLaughlin, C., Weizer, A., Su, Z., Boczkowski, D., Dannull, J., Vieweg, J., & Gilboa, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6275 · Cited by 164
Self-citationSynergy between tumor immunotherapy and antiangiogenic therapy
Nair, S., Boczkowski, D., Moeller, B., Dewhirst, M., Vieweg, J., & Gilboa, E. (2003) · Blood · doi:10.1182/blood-2002-12-3738 · Cited by 163
Self-citationNaftzger, C., Takechi, Y., Kohda, H., Hara, I., Vijayasaradhi, S., & Houghton, A. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14809 · Cited by 160
Kassiotis, G., Zamoyska, R., & Stockinger, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021812 · Cited by 159
Li, Y., Wang, M.-N., Li, H., King, K. D., Bassi, R., Sun, H., Santiago, A., Hooper, A. T., Böhlen, P., & Hicklin, D. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020072 · Cited by 153
OX-40: life beyond the effector T cell stage
Weinberg, A. D., Vella, A. T., & Croft, M. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0146 · Cited by 149
Development of antitumor immune responses in reconstituted lymphopenic hosts.
Hu, H., Poehlein, C. H., Urba, W. J., & Fox, B. A. (2002) · PubMed · Cited by 135
Ge, Q., Rao, V. P., Cho, B. K., Eisen, H. N., & Chen, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1728 · Cited by 132
Dendritic cells in cancer vaccines
Brossart, P., Wirths, S., Brugger, W., & Kanz, L. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00730-5 · Cited by 132
Fong, L. H., Ruegg, C. L., Brockstedt, D. G., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3113 · Cited by 128
Zajac, A. J., Murali‐Krishna, K., Blattman, J. N., & Ahmed, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80119-2 · Cited by 124
Roth, J., Dittmer, D. P., Réa, D., Tartaglia, J., Paoletti, E., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4781 · Cited by 118
Bronte, V., Apolloni, E., Ronca, R., Zamboni, P., Overwijk, W. W., Surman, D. R., Restifo, N. P., & Zanovello, P. (2000) · PubMed · Cited by 116
Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines
Simon, R. M., Steinberg, S. M., Hamilton, M., Hildesheim, A., Khleif, S. N., Kwak, L. W., Mackall, C. L., Schlom, J., Topalian, S. L., & Berzofsky, J. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1848 · Cited by 115
Targeting dendritic cells to enhance DNA vaccine potency.
You, Z., Huang, X. F., Hester, J. H., Toh, H. C., & Chen, S. (2001) · PubMed · Cited by 113
Lawrence, H. S. (1959) · Medical Entomology and Zoology · Cited by 112
Stutman, O. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.2.353 · Cited by 106
Zeis, M., Siegel, S., Wagner, A., Schmitz, M., Marget, M., Kühl-Burmeister, R., Adamzik, I.-D., Kabelitz, D., Dreger, P., Schmitz, N., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5391 · Cited by 105
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes
Grünebach, F., Müller, M. R., Nencioni, A., & Brossart, P. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301901 · Cited by 103
THE MOUSE MUTANT NUDE DOES NOT DEVELOP SPONTANEOUS TUMOURS.
Rygaard, J., & Povlsen, C. O. (1974) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology · doi:10.1111/j.1699-0463.1974.tb02299.x · Cited by 97
Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer
Bass, K. K., & Mastrangelo, M. J. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050498 · Cited by 96
Active immunotherapy with allogeneic tumor cell vaccines: present status.
Chan, A., & Morton, D. (1998) · PubMed · Cited by 88
Marrack, P., Mitchell, T., Bender, J., Hildeman, D. A., Kedl, R. M., Teague, T. K., & Kappler, J. W. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01245.x · Cited by 87
Melero, I., Singhal, M. C., McGowan, P., Haugen, H. S., Blake, J., Hellström, K. E., Yang, G., Clegg, C. H., & Chen, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3998-4004.1997 · Cited by 85
Escape from Host-Antitumor Immunity
Pawelec, G., Zeuthen, J., & Kiessling, R. W. (1997) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v8.i2-3.10 · Cited by 78
Bacteria and cancer--antagonisms and benefits.
Nauts, H. C. (1989) · PubMed · Cited by 70
de Gruijl, T. D., Bakker, S. A. L., Tillman, B. W., van den Eertwegh, A. J. M., Buter, J., Lougheed, S. M., van der Bij, G. J., Safer, A. M., Haisma, H. J., Curiel, D. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5322 · Cited by 67
New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells
Kwon, B., Lee, H. W., & Kwon, B. S. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02263-9 · Cited by 63
T-Cell turnover in vivo and the role of cytokines
Sprent, J., Zhang, X. M., Sun, S., & Tough, D. F. (1999) · Immunology Letters · doi:10.1016/s0165-2478(98)00119-9 · Cited by 44
Zhao, Y., Boczkowski, D., Nair, S. K., & Gilboa, E. (2003) · Blood · doi:10.1182/blood-2003-06-1867 · Cited by 36
Self-citationMoog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
Immunostimulatory monoclonal antibodies for cancer therapy
Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M., & Chen, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2051 · Cited by 627
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Metadata
- Authors
- Gilboa, E.
- Venue
- Nature Reviews Cancer
- Published
- 2004-05
- Volume
- 4
- Issue
- 5
- Pages
- 401-411
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1492054936
- Cited by
- 267
- References
- 142
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.